c-erbB-2 and p53 expression in fallopian tube carcinoma
- 15 June 1995
- Vol. 75 (12), 2891-2896
- https://doi.org/10.1002/1097-0142(19950615)75:12<2891::aid-cncr2820751216>3.0.co;2-b
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Regulation of the specific DNA binding function of p53Cell, 1992
- Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53Cell, 1992
- High Incidence of p53 Gene Mutation in Human Ovarian Cancer and Its Association with Nuclear Accumulation of p53 Protein and Tumor DNA AneuploidyJapanese Journal of Cancer Research, 1992
- NEU protein overexpression in benign, borderline, and malignant ovarian neoplasmsGynecologic Oncology, 1992
- Cisplatin-based combination chemotherapy in carcinoma of the fallopian tubeGynecologic Oncology, 1991
- Combination chemotherapy in advanced adenocarcinoma of the fallopian tubeGynecologic Oncology, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Primary carcinoma of the fallopian tube: Evidence for activity of cisplatin combination therapyGynecologic Oncology, 1987
- AnnouncementGynecologic Oncology, 1986
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958